Intravitreal and Subconjunctival Melphalan for Retinoblastoma in Transgenic Mice
Figure 1
Mean tumor burden (40x) for eyes at 1 week and 3 weeks following intravitreal injection of 1 mcg melphalan. Tumor inhibition was statistically significant after 1 week and after 3 weeks following intravitreal treatment.
